Real-time enrollment status for this narcolepsy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06752668 |
| Recruiting Status | Recruiting |
| Condition | Narcolepsy |
| Phase | Clinical Trial |
| Target Enrollment | 96 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Centessa Pharmaceuticals (UK) Limited |
| Last Updated on CT.gov | October 29, 2025 (Oct 29, 2025) |
As of March 2, 2026: Clinical trial NCT06752668 is currently recruiting participants. This clinical trial study for narcolepsy is actively seeking new participants at 25 locations across the United States. The study is sponsored by Centessa Pharmaceuticals (UK) Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06752668 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06752668 was last updated Oct 29, 2025 (October 29, 2025). HelloStudys verifies this status automatically.